ADAP
Adaptimmune Therapeutics PLC Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website adaptimmune.com
- Employees(FY) 534
- ISIN US00653A1079
Performance
-2.63%
1W
+7.77%
1M
-7.5%
3M
+122.0%
6M
+39.97%
YTD
-17.16%
1Y
Profile
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops SPEARHEAD-1 that is in phase II clinical trials with ADP-A2M4 for synovial sarcoma; SURPASS-3 that is in phase II clinical trial with ADP-A2M4CD8 for people with platinum resistant ovarian cancer; and SURPASS that is in phase I clinical trials in patients with head and neck, and urothelial cancers. The company has strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic and allogeneic T-cell therapies; co-development collaboration agreement with Universal Cells, Inc.; third-party collaborations with Noile-Immune and Alpine Immune Sciences; and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
Technical Analysis of ADAP 2024-05-10
Overview:
In analyzing the technical indicators for ADAP over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for informed deci...
Recent News & Updates
- 2023-11-07 18:30
- 2023-11-07 18:05
- 2023-11-07 05:15
- 2023-10-30 20:00
- 2023-10-30 20:00
- 2023-10-27 06:15
- 2023-10-24 20:06
- 2023-10-22 16:15
- 2023-09-10 20:00
- 2023-08-08 19:29
- 2023-08-03 01:24
- 2023-07-28 00:30
- 2023-07-19 19:28
- 2023-07-16 08:18
- 2023-06-28 21:18
Reata's (RETA) Skyclarys PAS Gets FDA Nod, Stock Rises 7%(Yahoo Finance)
- 2023-06-25 23:23
- 2023-06-25 23:15
- 2023-06-22 21:15
Horizon's (HZNP) Tepezza Study in Japan for TED Meets Goal(Yahoo Finance)
- 2023-06-21 21:40
- 2023-06-18 22:18
GSK Announces Extension of FDA Review for Rare Blood Therapy(Yahoo Finance)
- 2023-06-15 20:39
- 2023-06-14 21:43
- 2023-06-14 20:18
- 2023-06-12 22:14
- 2023-06-11 22:00
- 2023-06-11 21:48
- 2023-06-08 22:52
- 2023-06-05 18:50
Dr. Reddy's (RDY) Meets Goals in Actemra Biosimilar Study(Yahoo Finance)
- 2023-06-04 23:40
- 2023-06-04 22:22
Bristol Myers (BMY) Announces Upbeat Data From NSCLC Study(Yahoo Finance)